Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
NCT02070328 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-02-08
Summary
Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of patients over many years (called long-term follow-up) is needed because the long-term effects of proton therapy are not well known.
Conditions
Interventions
- OTHER
-
Registry
Sponsors & Collaborators
-
Provision Center for Proton Therapy
collaborator OTHER -
Center for Biomedical Research, LLC
lead OTHER
Principal Investigators
-
James R Gray, M.D. · Provision Center for Proton Therapy
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2050-01-31
- Completion
- 2050-01-31
Countries
- United States
Study Locations
More Related Trials
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
MR-simulation in Radiotherapy for Prostate Cancer
NCT03238170 ·Status: UNKNOWN ·Phase: NA
-
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NCT07130682 ·Status: RECRUITING ·Phase: NA
-
Proton Therapy for Low and Intermediate Risk Prostate Cancer
NCT00693238 ·Status: COMPLETED ·Phase: NA
-
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
NCT00831623 ·Status: COMPLETED ·Phase: NA
-
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NCT04725903 ·Status: RECRUITING ·Phase: NA
-
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
NCT02935023 ·Status: UNKNOWN ·Phase: PHASE2
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
NCT05010343 ·Status: RECRUITING ·Phase: PHASE2
-
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT01617161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy
NCT02793284 ·Status: COMPLETED ·Phase: NA
-
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase I Study MR-guided SBRT to PCa
NCT03935308 ·Status: WITHDRAWN ·Phase: NA
-
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer
NCT06105918 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
NCT03367702 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
NCT07015138 ·Status: RECRUITING ·Phase: NA
-
MRI-guided Locoregional SBRT Prostate Program
NCT07132073 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Radiation Therapy in Treating Patients With Prostate Cancer
NCT01434290 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00002703 ·Status: COMPLETED ·Phase: PHASE3
-
PSMA-PET Registry for Recurrent Prostate Cancer
NCT03718260 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00331773 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery
NCT01766492 ·Status: UNKNOWN
-
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT05183074 ·Status: RECRUITING ·Phase: NA
-
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
NCT02437539 ·Status: COMPLETED ·Phase: PHASE1